Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

TWEAKing for a fight with GVHD.

David J MacEwan1

  • 1UNIVERSITY OF LIVERPOOL.

Blood
|July 25, 2015
PubMed
Summary

Tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) signaling via its receptor fibroblast growth factor-inducible 14 (Fn14) drives intestinal apoptosis and mortality in graft-versus-host disease (GVHD). This pathway is critical for understanding GVHD pathogenesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Concise Guide to PHARMACOLOGY 2025/26: Catalytic receptors.

British journal of pharmacology·2025
Same author

The Concise Guide to PHARMACOLOGY 2023/24: Catalytic receptors.

British journal of pharmacology·2023
Same author

THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Catalytic receptors.

British journal of pharmacology·2021
See all related articles

Area of Science:

  • Immunology
  • Cell Biology
  • Gastroenterology

Background:

  • Graft-versus-host disease (GVHD) is a serious complication of hematopoietic stem cell transplantation.
  • Intestinal injury and apoptosis are key features of GVHD pathology.
  • The molecular mechanisms underlying GVHD-induced intestinal apoptosis require further elucidation.

Purpose of the Study:

  • To investigate the role of tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) and its receptor fibroblast growth factor-inducible 14 (Fn14) in GVHD.
  • To determine the contribution of the TWEAK/Fn14 pathway to intestinal apoptosis and mortality in a GVHD model.

Main Methods:

  • Utilized a murine model of acute GVHD.
  • Assessed intestinal apoptosis and tissue damage.
  • Analyzed the expression and function of TWEAK and Fn14 in GVHD.

Main Results:

  • Chopra et al. demonstrated that TWEAK ligand acting through its receptor Fn14 is crucial to intestinal apoptosis in GVHD.
  • The TWEAK/Fn14 pathway significantly contributes to the mortality associated with GVHD.
  • Inhibition of this pathway may ameliorate GVHD-induced intestinal damage.

Conclusions:

  • The TWEAK/Fn14 axis represents a critical mediator of intestinal apoptosis and mortality in GVHD.
  • Targeting the TWEAK/Fn14 pathway holds potential therapeutic implications for managing GVHD.
  • Further research into this pathway could lead to novel treatment strategies for transplant recipients.

Related Experiment Videos